ACTIVE

BioSenic

Financial year 2025 · Closed on 31/12/2025

Net result22,2 M €+458,0 %over 1 year

Equity-661,4 k €-151,8 %over 1 year

Identity

Source · BCE/KBO

BioSenic is a Public limited company incorporated in 2006. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Tubize.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0882.015.654
Incorporation: 22/06/2006
Legal form: Public limited company
Registered office: Avenue Léon Champagne 3
1480 Tubize · WallonieSee on map
Contributed capital: 54 199 423,72 €
Latest accounts: 31/12/2025

Activities (NACE)

72109Research and experimental development on natural sciences and engineering· main 72190Other research and experimental development on natural sciences and engineering 73100Advertising

Joint committees (2)

Contacts

4 public details availableLog in to view

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 29 filings

Trend over 9 financial years

	2025		2014		2013		2012		2011
Income statement
Gross margin	–		4,3 M €	-7.0%	4,6 M €	+4.7%	4,4 M €	+39.5%	3,1 M €
EBITDA	22,6 M €	+30284%	-74,9 k €	-104%	2 M €	+48.5%	1,4 M €	+428%	-412,7 k €
Operating result	22,2 M €	+470%	-6 M €	-87.0%	-3,2 M €	-26.6%	-2,5 M €	-7.6%	-2,4 M €
Net result	22,2 M €	+458%	-6,2 M €	-91.5%	-3,2 M €	-27.9%	-2,5 M €	-9.0%	-2,3 M €
Balance sheet
Equity	-661,4 k €	-152%	1,3 M €	-76.6%	5,5 M €	-24.2%	7,2 M €	+0.1%	7,2 M €
Total assets	3,4 M €	-87.2%	26,5 M €	+58.3%	16,7 M €	-5.5%	17,7 M €	+20.2%	14,7 M €
Cash	67,1 k €	-99.3%	10,1 M €	+1611%	588,1 k €	-71.5%	2,1 M €	-29.0%	2,9 M €
Debts	4,1 M €	-79.4%	19,8 M €	+260%	5,5 M €	+1.1%	5,4 M €	+42.9%	3,8 M €
Other
Workforce	–		37,1 ETP	-2.6%	38,1 ETP	-5.5%	40,3 ETP	-4.3%	42,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 57 ended

Active mandates

Anne-Sophie Jourdain

Mandate

Active

BOLETUS CONSULTING

Mandate · 0833.666.597

Active

Capital Grand Est

Mandate

Represented by Virginie Miath

Active

CarKath

Mandate · 0811.816.556

Represented by Eric Halioua

Active

FINSYS MANAGEMENT

Mandate · 0558.913.406

Represented by Jean-Luc Vandebroek

Active

IRYL Partners

Mandate · 1027.234.453

Active

Ended mandates

Paul MAGREZ

Director · since 05 février 2015 · until 23 mai 2019

Ended

Roland BARON

Director · since 05 février 2015 · until 23 mai 2019

Ended

ENRICO BASTIANELLI sprl

Managing director · since 16 janvier 2015 · until 23 mai 2019 · 0883.830.544

Represented by ENRICO BASTIANELLI

Ended

PARTIGEST-GARANCE SA

Director · since 16 janvier 2015 · until 25 mai 2017 · 0478.942.646

Represented by Jacques REYMANN

Ended

Other companies at this address

Avenue Léon Champagne 3 1480 Tubize

Company	CBE no.
OpenS● Active	0821.802.905

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Consolidated accounts	Consolidated accounts	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	01/12/2025	16/07/2024	17/07/2023	06/07/2022	24/06/2021
General meeting	10/06/2026	30/10/2025	12/07/2024	14/06/2023	08/06/2022	09/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 29 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	10/06/2026	02/07/2026	French	PDF
Full model	31/12/2024	30/10/2025	01/12/2025	French	PDF
Full model	31/12/2023	12/07/2024	16/07/2024	French	PDF
Consolidated accounts	31/12/2023	12/07/2024	16/07/2024	French	PDF
Full model	31/12/2022	14/06/2023	05/07/2023	French	PDF
Consolidated accounts	31/12/2022	14/06/2023	17/07/2023	French	PDF
Full model	31/12/2021	08/06/2022	20/06/2022	French	PDF
Consolidated accounts	31/12/2021	08/06/2022	06/07/2022	French	PDF
Full model	31/12/2020	09/06/2021	24/06/2021	French	PDF
Consolidated accounts	31/12/2020	09/06/2021	23/06/2021	French	PDF
Full model	31/12/2019	10/06/2020	15/06/2020	French	PDF
Consolidated accounts	31/12/2019	10/06/2020	15/06/2020	French	PDF
Full model	31/12/2018	12/06/2019	20/06/2019	French	PDF
Consolidated accounts	31/12/2018	21/03/2019	20/06/2019	French	PDF
Full model	31/12/2017	13/06/2018	18/06/2018	French	PDF
Consolidated accounts	31/12/2017	13/06/2018	18/06/2018	French	PDF
Full model	31/12/2016	26/05/2017	08/06/2017	French	PDF
Consolidated accounts	31/12/2016	26/05/2017	08/06/2017	French	PDF
Full model	31/12/2015	26/05/2016	24/06/2016	French	PDF
Consolidated accounts	31/12/2015	26/05/2016	28/06/2016	French	PDF
Abridged model	31/12/2014	28/05/2015	26/06/2015	French	PDF
Consolidated accounts	31/12/2014	28/05/2015	29/06/2015	French	PDF
Abridged model	31/12/2013	22/05/2014	28/05/2014	French	PDF
Abridged model	31/12/2012	10/06/2013	11/07/2013	French	PDF
Abridged model	31/12/2011	24/05/2012	06/08/2012	French	PDF
Abridged model	31/12/2010	26/05/2011	26/08/2011	French	PDF
Abridged model	31/12/2009	27/05/2010	24/08/2010	French	PDF
Abridged model	31/12/2008	28/05/2009	26/06/2009	French	PDF
Abridged model	31/12/2007	20/08/2008	15/09/2008	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 57 ended

Active mandates

Anne-Sophie Jourdain

Mandate

Active

BOLETUS CONSULTING

Mandate · 0833.666.597

Active

Capital Grand Est

Mandate

Represented by Virginie Miath

Active

CarKath

Mandate · 0811.816.556

Represented by Eric Halioua

Active

FINSYS MANAGEMENT

Mandate · 0558.913.406

Represented by Jean-Luc Vandebroek

Active

IRYL Partners

Mandate · 1027.234.453

Active

Ended mandates

Paul MAGREZ

Director · since 05 février 2015 · until 23 mai 2019

Ended

Roland BARON

Director · since 05 février 2015 · until 23 mai 2019

Ended

ENRICO BASTIANELLI sprl

Managing director · since 16 janvier 2015 · until 23 mai 2019 · 0883.830.544

Represented by ENRICO BASTIANELLI

Ended

PARTIGEST-GARANCE SA

Director · since 16 janvier 2015 · until 25 mai 2017 · 0478.942.646

Represented by Jacques REYMANN

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates03/06/2026
DEMISSIONS, NOMINATIONS
PDF
Other20/04/2026
DIVERS
PDF
Other08/12/2025
DIVERS
PDF
Mandates17/10/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates15/09/2025
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Other09/05/2025
DIVERS
PDF
Capital / shares18/04/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Capital / shares08/04/2025
CAPITAL, ACTIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202522,2 M €↑
2025
Name changeBioSenic
2014
Annual accounts 2014-6,2 M €↓
2013
Annual accounts 2013-3,2 M €↓
2012
Annual accounts 2012-2,5 M €↓
2011
Annual accounts 2011-2,3 M €↓
2010
Annual accounts 2010-251,8 k €↑
2009
Annual accounts 2009-1,2 M €↓
2008
Annual accounts 2008-534,3 k €↓
2007
Annual accounts 2007-480,6 k €
2007
Name changeBONE THERAPEUTICS
22/06/2006
IncorporationPublic limited company

BioSenic

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline